EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY 4.0

Botulinum Toxin Type A for Preventing Facial Trauma and Hypertrophic Scars: A Meta‐Analysis and Trial Sequential Analysis

Jie Lu, Yuhua Chen, Hongxia Xie, Yiming Wang iD

Journal of Cosmetic Dermatology · 2025-11 · 24 (11)

DOI: 10.1111/jocd.70501 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Journal of Cosmetic Dermatology, online erschienen am 28.10.2025. Verfasst von Jie Lu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical Cosmetic Center, Chengdu Second People's Hospital, Chengdu, China. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Cicatrix, Hypertrophic, Facial Injuries, Neuromuscular Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the effectiveness and safety of local injection of botulinum toxin type A in preventing hypertrophic scars after facial trauma and surgery using meta‐analysis and sequential experimental analysis methods.

Method

Computer retrieval of randomized controlled trials on the prevention of facial scars with botulinum toxin type A from PubMed, EMbase, the Cochrane Library, CNKI, China Biomedical Literature Service System, Wanfang Database, and VIP Chinese Science and Technology Journal Full text Database up to February 2025.

Result

Twelve randomized controlled clinical trials were included, with a total of 644 patients; Type A botulinum toxin injection is superior to the control group in improving patient satisfaction [ RR = 6.89; 95% CI (3.20, 14.85); p < 0.0001], Vancouver Scale score [ RR = −1.40; 95% CI (−2.73, 0.08); p < 0.0001], visual analog score [ RR = 1.41; 95% CI (0.26, 2.56); p = 0.02], scar width [ RR = −0.14; 95% CI (−0.17, −0.10); p < 0.0001], and the difference is significant; The incidence of adverse events [ RR = 0.38; 95% CI (0.18, 0.84); p = 0.02] and recurrence rate [ RR = 0.17; 95% CI (0.04, 0.81); p < 0.03] were lower than those in the control group, and no serious adverse reactions occurred; Sensitivity analysis showed that the results were relatively robust, sequential analysis of the experiment showed that the benefits were conclusive, and Begg's and Egger's tests showed no publication bias.

Conclusion

Type A botulinum toxin injection has a certain therapeutic effect on hypertrophic scars without significant side effects. However, the accuracy and stability of its therapeutic effect still require more high‐quality research verification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum Toxins, Type ACicatrix, HypertrophicFacial InjuriesNeuromuscular AgentsHumansRandomized Controlled Trials as TopicTreatment OutcomePatient Satisfaction

Stichwörter der Autor:innen

meta analysisscarsequential analysis of experimentssystem evaluationtype A botulinum toxin

Substanzen

Botulinum Toxins, Type ANeuromuscular Agents

Autor:innen und Institutionen

  • Medical Cosmetic Center, Chengdu Second People's Hospital, Chengdu, China.
  • Department of Dermatology, The Second People's Hospital of Chengdu, China.

ORCID-Profile: Yiming Wang

Zitieren

APA

Lu, J., Chen, Y., Xie, H., & Wang, Y. (2025). Botulinum Toxin Type A for Preventing Facial Trauma and Hypertrophic Scars: A Meta‐Analysis and Trial Sequential Analysis. Journal of Cosmetic Dermatology, 24(11). https://doi.org/10.1111/jocd.70501

Vancouver

Lu J, Chen Y, Xie H, Wang Y. Botulinum Toxin Type A for Preventing Facial Trauma and Hypertrophic Scars: A Meta‐Analysis and Trial Sequential Analysis. Journal of Cosmetic Dermatology. 2025;24(11). doi:10.1111/jocd.70501

BibTeX
@article{Lu2025,
  author = {Lu, Jie and Chen, Yuhua and Xie, Hongxia and Wang, Yiming},
  title = {Botulinum Toxin Type A for Preventing Facial Trauma and Hypertrophic Scars: A Meta‐Analysis and Trial Sequential Analysis},
  journal = {Journal of Cosmetic Dermatology},
  year = {2025},
  volume = {24},
  number = {11},
  doi = {10.1111/jocd.70501}
}
Kostenlos starten →